Cellebrite DI (CLBT) Enterprise Value (2020 - 2025)

Cellebrite DI's Enterprise Value history runs 6 years deep, the most recent figure standing at -$276.0 million for Q4 2025.

• On a quarterly basis, Enterprise Value rose 5.95% year-over-year to -$276.0 million in Q4 2025; TTM through Dec 2025 was -$276.0 million, a 5.95% increase from a year earlier, with the FY2025 full-year figure at -$276.0 million, up 5.95% from the prior year.
• Enterprise Value grew to -$276.0 million in Q4 2025 per CLBT's latest filing, from -$281.4 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$84.6 million in Q3 2022 and bottomed at -$293.5 million in Q4 2024.
• The 5-year median for Enterprise Value is -$131.0 million (2022), against an average of -$155.2 million.
• Biggest YoY gain for Enterprise Value was 26.1% in 2025; the steepest drop was 106.35% in 2025.
• Year by year, Enterprise Value stood at -$146.0 million in 2021, then advanced by 4.79% to -$139.0 million in 2022, then sank by 90.12% to -$264.2 million in 2023, then declined by 11.07% to -$293.5 million in 2024, then increased by 5.95% to -$276.0 million in 2025.
• Per Business Quant, the three latest CLBT Enterprise Value figures stand at -$276.0 million (Q4 2025), -$281.4 million (Q3 2025), and -$179.2 million (Q2 2025).